The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular residual disease (MRD) interception in locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC): MERIDIAN study.
 
Enrique Sanz Garcia
Research Funding - Novartis Canada Pharmaceuticals Inc
 
Anna Spreafico
Honoraria - Immunocore
Consulting or Advisory Role - Bristol-Myers Squibb; Immunocore; Medison; Merck
Research Funding - Alentis Therapeutics (Inst); Alkermes (Inst); ALX Oncology (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Nubiyota (Inst); Pfizer (Inst); Replimune (Inst); Roche (Inst); Seagen (Inst); SERVIER (Inst); Surface Oncology (Inst); Symphogen (Inst); Treadwell Therapeutics (Inst)
 
Ali Hosni
(OPTIONAL) Uncompensated Relationships - Elekta
 
Andrew McPartlin
Consulting or Advisory Role - Tolmar; Tolmar; Tolmar
 
Chiaojung Jillian Tsai
Employment - Princess Margaret Cancer Centre
Honoraria - Varian Medical Systems; Varian Medical Systems; Varian Medical Systems
Consulting or Advisory Role - Varian Medical Systems
 
Lawson Eng
No Relationships to Disclose
 
Mercedes Herrera
Speakers' Bureau - AstraZeneca Spain
Travel, Accommodations, Expenses - Roche
 
David Paul Goldstein
Stock and Other Ownership Interests - Pfizer (I)
 
Andrew Hope
No Relationships to Disclose
 
John R de Almeida
Honoraria - Cardinal Health; EMD Serono
Research Funding - cardinal health; GlaxoSmithKline
 
Ezra Hahn
No Relationships to Disclose
 
Christopher Yao
No Relationships to Disclose
 
John Waldron
No Relationships to Disclose
 
Bayardo Perez-Ordonez
Honoraria - AstraZeneca
 
Patricia Inocillas
No Relationships to Disclose
 
Bana Ambasager
Employment - NeoGenomics Laboratories
 
Christopher Gareth Smith
Employment - NeoGenomics Laboratories
 
Scott Victor Bratman
Employment - Adela
Leadership - Adela
Stock and Other Ownership Interests - Adela
Patents, Royalties, Other Intellectual Property - Co-inventor and holder of a patent related to circulating tumor DNA detection technology.; Co-inventor of patent application pending related to detection of HPV circulating cell-free DNA. (Inst); Co-inventor of patents related to cell-free DNA methylation analysis technology. (Inst)
 
Lillian L. Siu
Leadership - Treadwell Therapeutics (I)
Stock and Other Ownership Interests - Agios (I)
Consulting or Advisory Role - Amgen; Arvinas; AstraZeneca/MedImmune; Daiichi Sankyo/UCB Japan; GlaxoSmithKline; LTZ Therapeutics; Marengo Therapeutics; Medicenna; Merck; Navire; Pangea; Relay Therapeutics; Roche; Seagen; Tubulis GmbH; Voronoi Health Analytics
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVID Radiopharmaceuticals (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Intensity Therapeutics (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Shattuck Labs (Inst); Symphogen (Inst)